This compound is a modified nucleoside phosphoramidite building block used in the solid-phase synthesis of oligonucleotides. Its structure features multiple protective groups, including a dimethoxytrityl (DMT) group for 5'-hydroxyl protection and a cyanoethyl phosphoramidite moiety for internucleotide linkage formation.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 206055-82-5
DMTr-LNA-C(Bz)-3-CED-phosphoramidite
oligonucleotide synthesis building block
5'-ODMT cEt N-Bzm5 C Phosphoramidite (Amidite)
Modified nucleoside phosphoramidite for oligonucleotide synthesis
(1R,3R,4R,7S)-3-(6-N-Benzoyladenin-9-yl)-7-(2-cyanoethoxy(diisopropylamino)phosphinoxy)-1-(4,4'-dimethoxytrityloxymethyl)-2,5-dioxabicyclo(2.2.1)heptane
phosphoramidite building block for oligonucleotide synthesis
Dmt-loct phosphoramidite
oligonucleotide building block reagent
I-bu-rG Phosphoramidite
oligonucleotide synthesis building block
Boc-His(Trt)-Aib-OH
peptide synthesis intermediate
Edaravone Impurity 12
Impurity reference standard for edaravone
2-(Trifluoromethyl)cinnamic acid
Pharmaceutical intermediate for trifluoromethylated compounds
N-[1-[(1R,3R,4R,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-[2-cyanoethoxy-[di(propan-2-yl)amino]phosphanyl]oxy-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methyl-2-oxopyrimidin-4-yl]benzamide
XHILZPWJJJDDDY-HXAWEXODSA-N
CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)[C@H]3[C@H]4[C@@H]([C@@](O3)(CO4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)OP(N(C(C)C)C(C)C)OCCC#N
—